Steffen-Sebastian Bolz is a scientist, physician and entrepreneur. He is a Co-Founder and Chief Scientific Officer (CSO) of Aphaia Pharma and Founder, CSO and Chief Medical Officer (CMO) of Qanatpharma. Dr. Bolz holds a full professorship at the University of Toronto, is a Principal Investigator at the Ted Rogers Centre for Heart Research and Director of the Toronto Centre for Microvascular Medicine. His research program has contributed novel signaling paradigms, methodological advancements and validated innovative molecular/therapeutic targets in the emerging field of microvascular medicine. Dr. Bolz holds a medical degree and a doctorate from the universities of Lübeck and Munich, Germany.